IRADIMED CORPORATION (IRMD)

IRADIMED CORPORATION Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	51.16	52.23	49.76	57.96	62
Short-Term Investments	-	-	-	-	0.5
Cash & Short-Term Investments	51.16	52.23	49.76	57.96	62.5
Cash Growth	-2.06%	4.97%	-14.14%	-7.27%	20.25%
Accounts Receivable	13.67	10.56	12.22	13.27	5.14
Inventory	11.62	10.4	12.82	5.37	4.3
Other Current Assets	4.76	2.05	1.19	0.89	4.31
Total Current Assets	81.2	75.24	76	77.49	76.24
Net Property, Plant & Equipment	23.86	16.81	11.33	4.61	4.55
Other Intangible Assets	3.38	3.1	2.52	2.07	1.12
Other Long-Term Assets	0.33	3.17	2.3	1.35	0.97
Total Assets	108.78	98.33	92.16	85.51	82.88
Accounts Payable	1.82	1.9	1.86	1.8	0.78
Accrued Expenses	3.36	3.89	3	3.09	3.06
Current Portion of Leases	-	-	0.43	0.29	0.28
Unearned Revenue	2.87	2.26	2.57	3.37	2.55
Other Current Liabilities	2.13	0.47	8.48	-	0.15
Total Current Liabilities	10.18	8.51	16.33	8.55	6.82
Long-Term Leases	-	0	1.62	1.91	2.21
Other Long-Term Liabilities	3.98	2.99	2.79	1.38	1.68
Total Long-Term Liabilities	3.98	3	4.41	3.29	3.88
Total Liabilities	14.16	11.51	20.74	11.84	10.71
Common Stock	0	0	0	0	0
Additional Paid-in Capital	30.39	30.03	28.16	26.41	25.16
Accumulated Other Comprehensive Income	-	-	-	-	0.02
Retained Earnings	64.23	56.79	43.26	47.26	46.99
Shareholders' Equity	94.62	86.82	71.42	73.67	72.17
Total Liabilities & Equity	108.78	98.33	92.16	85.51	82.88
Total Debt	0	0	2.04	2.21	2.48
Net Cash (Debt)	51.16	52.23	47.72	55.76	60.02
Net Cash Growth	-2.05%	9.46%	-14.41%	-7.10%	21.83%
Net Cash Per Share	3.98	4.09	3.75	4.41	4.77
Book Value	94.62	86.82	71.42	73.67	72.17
Book Value Per Share	7.36	6.79	5.61	5.83	5.73
Tangible Book Value	91.23	83.72	68.9	71.6	71.06
Tangible Book Value Per Share	7.10	6.55	5.42	5.67	5.64

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q